Blackstone Announces the Launch of a New Company with Intellia Therapeutics and Cellex Cell Professionals GmbH
June 22, 2021
0
Blackstone Life Sciences, Intellia Therapeutics and Cellex Cell Professionals New Company Blackstone (BX) announced that funds managed by Blackstone Life Sciences have committed $250 million towards the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell therapy company with Intellia Therapeutics (